Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 1/2015

Ausgabe 1/2015

Inhaltsverzeichnis ( 18 Artikel )

01.04.2015 | editorial | Ausgabe 1/2015

Multiple myeloma: the biology, the clinic, and the future

Priv. Doz. Dr. Niklas Zojer

01.04.2015 | editorial | Ausgabe 1/2015

Lymphoma: anything new?

Eberhard Gunsilius MD

01.04.2015 | review | Ausgabe 1/2015

Is dosing in oncology gender-sensitive?

Christine Marosi MD

01.04.2015 | short review | Ausgabe 1/2015

Tailoring treatment in myeloma: are there clues from biology?

Priv. Doz. Dr. Niklas Zojer, Heinz Ludwig

01.04.2015 | original report | Ausgabe 1/2015

New drugs on the horizon. Treatment of myeloma in 2020, a perspective

Prof. Dr. Heinz Ludwig, Wolfgang Hilbe, Niklas Zojer

01.04.2015 | short review | Ausgabe 1/2015

Is more better in myeloma? Treatment intensity and outcome in newly diagnosed myeloma patients

Michael Fillitz, Adelheid Seebacher, Michael Panny

01.04.2015 | short review | Ausgabe 1/2015

To maintain or not to maintain: treatment forever in myeloma?

Wolfgang Willenbacher MD, Ella Willenbacher MD

01.04.2015 | short review | Ausgabe 1/2015

Treatment of myeloma patients with renal impairment

Daniel Lechner

01.04.2015 | case report | Ausgabe 1/2015

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in a myeloma patient with terminal renal failure and hepatitis C with high viral load

Priv. Doz. Dr. Niklas Zojer, Michael Gschwantler, Wolfgang Hilbe

01.04.2015 | short review | Ausgabe 1/2015

Clinical update: B-cell receptor kinase inhibitors in chronic lymphocytic leukemia

Lukas Weiss MD, PhD, Thomas Melchardt MD, Alexander Egle MD

01.04.2015 | short review | Ausgabe 1/2015

PET in lymphoma: who, when, how often, pitfalls?

Christian Uprimny MD

01.04.2015 | short review | Ausgabe 1/2015

Beyond R-CHOP: treatment of double hit, tripple hit, MYC + NHL?

Michael A. Fridrik MD

01.04.2015 | short review | Ausgabe 1/2015

A critical update on prognostic and predictive biomarkers in malignant pleural mesothelioma

Bahil Ghanim MD, Mir Alireza Hoda MD, Thomas Klikovits MD, Balazs Dome MD, PhD, Michael Grusch PhD, Martin Filipits PhD, Walter Klepetko MD, Walter Berger PhD, Balazs Hegedus PhD

01.04.2015 | short review | Ausgabe 1/2015

Optimal follow-up of ovarian cancer patients

Eduard Vrdoljak MD, PhD, Branka Petrić Miše MD, Tihana Boraska Jelavić MD, PhD, Snježana Tomić MD, PhD, Dinka Šundov MD, PhD, Ante Strikić MD

01.04.2015 | short review | Ausgabe 1/2015

Optimal follow-up of endometrial cancer patients

Eduard Vrdoljak MD, PhD, Tihana Boraska Jelavić MD, PhD, Branka Petrić Miše MD, PhD

01.04.2015 | short review | Ausgabe 1/2015

Optimal follow-up of cervical cancer patients

Eduard Vrdoljak MD, PhD, Tihana Boraska Jelavić MD, PhD, Branka Petrić Miše MD, PhD, Tomislav Omrčen MD, PhD

01.04.2015 | review | Ausgabe 1/2015

Radiotherapy for brain metastases: are we getting better?

Dr. Leor Zach MD, Dr. Alisa Talianski MD, Dr. Yaakov Richard Lawrence MBBS, MA, MRCP

01.04.2015 | review | Ausgabe 1/2015

Predicting drug sensitivity by 3D cell culture models

Arno Amann MD, Gabriele Gamerith MD, Julia M. Huber PhD, Marit Zwierzina MD, Wolfgang Hilbe MD, Heinz Zwierzina MD

Aktuelle Ausgaben